ESC Professional Premium Access

Effects of CYP3A4*22 carrier and CYP3A5 expressor status on clinical outcome in patients treated with ticagrelor for acute coronary syndrome

Congress Presentation

About the speaker

Doctor Jaouad Azzahhafi

St Antonius Hospital, Nieuwegein (Netherlands (The))
0 follower

4 more presentations in this session

P2Y12 inhibitors monotherapy in patients undergoing complex vs. non-complex percutaneous coronary intervention: a meta-analysis of randomized trials

Speaker: Doctor A. Oliva (New York, IT)


Liposomal docosahexaenoic acid halts atherosclerosis progression

Speaker: Miss S. Chong (Singapore, SG)


The effect of vitamin k2 supplementation on coronary artery disease in a randomized multicenter trial

Speaker: Doctor S. Hasific (Odense, DK)


Comparison of the Efficacy and Safety between different Oral P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome: a Systematic Review and Meta-Analysis

Speaker: Doctor A. Lepone (Pisa, IT)


Access the full session

Coronary artery disease - Pharmacotherapy 2

Speakers: Doctor J. Azzahhafi, Doctor A. Oliva, Miss S. Chong, Doctor S. Hasific, Doctor A. Lepone

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb